Transcriptomics

Dataset Information

0

High-throughput Drug Screening Identifies Fluoxetine as a Potential Therapeutic Agent for Neuroendocrine Prostate Cancer


ABSTRACT: Here, we performed a high-throughput drug screening and identified fluoxetine, originally an FDA-approved antidepressant, as candidate therapeutic agent for NEPC. In vitro experiments revealed that fluoxetine effectively curbed the neuroendocrine differentiation and inhibited the cell viability by targeting the AKT pathway. Altogether, this work repurposed fluoxetine for antitumor application, and supported its clinical development for NEPC therapy, which may provide a promising therapeutic strategy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE224715 | GEO | 2023/04/05

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-01-01 | GSE225007 | GEO
2013-12-31 | E-GEOD-43261 | biostudies-arrayexpress
2015-06-09 | E-GEOD-51904 | biostudies-arrayexpress
2015-06-09 | GSE51904 | GEO
2013-12-31 | GSE43261 | GEO
2022-09-04 | GSE193040 | GEO
2022-09-04 | GSE194289 | GEO
2007-07-04 | GSE6476 | GEO
| PRJNA932252 | ENA
2008-06-14 | E-GEOD-6476 | biostudies-arrayexpress